CTLA4 and systemic lupus erythematosus: This phenomenon was supported by data from 48 h post-activation, where the expression levels of CD4+ CTLA4+ and CD3+ CTLA4+ were significantly highest in the control group, and the increase in expression was significantly different from that in SLE patients.